“Poly-ε-caprolactone microspheres containing interferon alpha as alternative formulations for the treatment of chronic hepatitis C” (2012) Brazilian Journal of Pharmaceutical Sciences, 48(1), pp. 51–59. doi:10.1590/S1984-82502012000100006.